Evidence map›Paper›PMID 35395019›Full record

ArticlePloS one2022

Awareness, attitudes and acceptability of the HPV vaccine among female university students in Morocco.

A Yacouti, N Elkhoudri, A El Got, A Benider, F Hadrya, R Baddou, A Forster, M Mouallif

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. HPV Vaccination in Morocco: Quiet Progress or Public Health Failure?Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

A YacoutiLaboratory of Health Sciences and Technologies, Epidemiology and Biomedical Unit, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.
N ElkhoudriLaboratory of Health Sciences and Technologies, Epidemiology and Biomedical Unit, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.
A El GotLaboratory of Health Sciences and Technologies, Epidemiology and Biomedical Unit, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.
A BeniderFaculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
F HadryaLaboratory of Health Sciences and Technologies, Epidemiology and Biomedical Unit, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.
R BaddouLaboratory of Health Sciences and Technologies, Epidemiology and Biomedical Unit, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.ORCID 0000-0002-7744-7383
A ForsterDepartment of Behavioural Science and Health, Institute of Epidemiology & Health, University College London, London, United Kingdom.
M MouallifLaboratory of Health Sciences and Technologies, Epidemiology and Biomedical Unit, Higher Institute of Health Sciences, Hassan First University of Settat, Settat, Morocco.
Université Hassan 1er · MAUniversity College London · GBUniversity of Hassan II Casablanca · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Morocco, cervical cancer is the second most common cancer affecting women behind breast cancer. The Human PapillomaVirus (HPV) vaccine has been available in Morocco since 2008 but its introduction in the national immunization program is still under discussion. There is limited data regarding acceptability and predictors of HPV vaccine acceptability among Moroccan young women. This study aimed to evaluate the awareness of female university students of HPV and the vaccine and to identify predictors of HPV vaccine acceptability.

methodsWe conducted a structured interviewer-administered questionnaire with 1087 participants in six Moroccan universities between May 2019 and June 2020.

resultsThe awareness of HPV infection was 14.7% and of HPV vaccine was 7.8%. The rate of immunization coverage against HPV was less than 1%. Over 67% of participants were willing to receive the HPV vaccine. Awareness of cervical cancer (p-Value = 0.04) and the HPV vaccine (p-Value = 0.01), and acceptability of Pap smear test (p-Value <0.01) were significant predictors of HPV vaccine acceptability.

conclusionsThis study revealed an insufficient amounts of awareness of HPV and of HPV vaccine uptake in a sample of Moroccan university young women. This lack of awareness needs intervention, and it is important to develop an awareness program for young female population either within or outside universities in order to promote vaccination uptake and ultimately lower the cervical cancer rate in Morocco.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsFemaleHealth Knowledge, Attitudes, PracticeHumansMoroccoPatient Acceptance of Health CareStudentsSurveys and QuestionnairesUniversitiesPapillomavirus Vaccines

Identifiers

PMID35395019
PMCPMC8993020
OpenAlexW4225819589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.